AHRQ's Clancy Discusses Comparative Effectiveness Research/Personalized Medicine Convergence at PMC Conference

Speaking at a conference hosted by the Personalized Medicine Coalition, Clancy emphasized that AHRQ is in the business of conducting research, not setting healthcare policy. As such, the agency will continue to investigate personalized medicine interventions to inform the work of the CDC and EGAPP.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.